Dermal Fillers
MAILI references stocked by ALLPARA for professional use, sourced direct and certified on every shipment.
CE Marked
SKU 10914
MaiLi Extreme
In stock
Volume
4 x 1 mL
Laboratory
Sinclair Pharma
Origin
Schweiz
Indication
Strong facial volumisation and structural correction
Treatment areas
Trade price and history are verified-only
allpara supplies licensed practitioners. Sign in or apply for a B2B account to see live pricing, volume tiers and price history.
MaiLi Extreme is an injectable hyaluronic acid dermal filler manufactured by Sinclair Pharma in Switzerland, with 24 mg/mL hyaluronic acid. As a MaiLi Extreme filler, it is a hyaluronic acid gel cross-linked with BDDE, designed for facial volume restoration, including volume loss from HIV-associated lipoatrophy. The product contains lidocaine 3 mg/mL for a more comfortable injection experience, is injected into the subcutaneous fat tissue or supraperiosteal zone, is supplied as four 1 mL syringes with four 27G x 1/2" needles, and is intended strictly for professional use.
Key Benefits of MaiLi Extreme
- Provides facial volume restoration
- Highest hyaluronic acid concentration in the MaiLi range (24 mg/mL)
- For reconstruction of structural defects, including HIV-associated lipoatrophy
- Injected into the subcutaneous fat or supraperiosteal zone by trained specialists
- Contains lidocaine 3 mg/mL for improved treatment comfort
- Hyaluronic acid cross-linked with BDDE
- CE-marked medical device (CE 2797)
Indications and Professional Use
Main indications
- Restoration of facial volume
- Structural defect correction, including congenital or medically related facial volume defects
- Volume loss due to HIV-associated lipoatrophy
Professional use
MaiLi Extreme is for use by authorised healthcare professionals only, injected into the subcutaneous fat tissue or the supraperiosteal zone - reserved to specialists specifically trained in these injection techniques. Composition: cross-linked (BDDE) hyaluronic acid 24 mg/mL of biofermentative origin, with lidocaine hydrochloride 3 mg/mL, in phosphate buffer. Supplied as four 1 mL pre-filled syringes with four 27G x 1/2" needles. Contraindicated in: known hypersensitivity to hyaluronic acid, lidocaine or amide-type local anaesthetics; history of severe allergy or anaphylaxis; autoimmune disease; porphyria; cutaneous disorders, inflammation or infection at or near the treatment site; bleeding disorders or treatment with thrombolytics or anticoagulants; tendency to keloid or hypertrophic scarring; pregnancy or breastfeeding; children.
Treatment areas
- Face
Patient profile
Suitable for adult patients seeking facial volume restoration or reconstruction of structural defects including volume loss from HIV-associated lipoatrophy, as assessed by a qualified practitioner. Not for use in patients with hypersensitivity to hyaluronic acid, lidocaine or amide anaesthetics; autoimmune disease; porphyria; bleeding disorders or anticoagulant therapy; a tendency to keloid or hypertrophic scarring; or during pregnancy or breastfeeding, and not for children. Injection into the subcutaneous fat or supraperiosteal zone is reserved to specialists specifically trained in these techniques.
How MaiLi Extreme Works
MaiLi Extreme is a cross-linked hyaluronic acid gel of biofermentative origin, cross-linked with BDDE, containing hyaluronic acid at 24 mg/mL - the highest in the MaiLi range - with lidocaine hydrochloride 3 mg/mL to reduce discomfort during injection. It is injected into the subcutaneous fat tissue or the supraperiosteal zone by an authorised healthcare professional trained in these techniques, using the supplied 27G x 1/2" needle, for facial volume restoration, including volume loss from HIV-associated lipoatrophy. The gel creates volume that corrects facial anatomy and is fully resorbed over time; how long the effect lasts depends on the quantity injected, the depth of placement and the patient's metabolism.
Why Order From Allpara
Allpara offers genuine, verified MAILI products from vetted suppliers, with full batch-traceability and expert support. We serve clinics and aesthetic professionals with CE-certified products, fast EU-wide delivery from our EU warehouse, and competitive trade pricing. Our focus is your patients' safety, satisfaction and results - with dedicated after-sales support for your peace of mind.
Frequently Asked Questions
How long does MaiLi Extreme last?
The gel is fully resorbed over time; how long the effect lasts depends on the quantity injected, the depth of placement and the patient's metabolism.
Which areas can be treated with MaiLi Extreme?
The face, for facial volume restoration and reconstruction of structural defects including volume loss from HIV-associated lipoatrophy. It is injected into the subcutaneous fat or supraperiosteal zone.
What is in MaiLi Extreme?
Cross-linked (BDDE) hyaluronic acid at 24 mg/mL of biofermentative origin - the highest in the MaiLi range - with lidocaine hydrochloride 3 mg/mL, in phosphate buffer.
More from Sinclair
ELLANSÉ references stocked by ALLPARA for professional use, sourced direct and certified on every shipment.
ELLANSÉ Products
View all 2
LANLUMA references stocked by ALLPARA for professional use, sourced direct and certified on every shipment.
LANLUMA Products
View all 2
PERFECTHA references stocked by ALLPARA for professional use, sourced direct and certified on every shipment.
PERFECTHA Products
View all 8
SILHOUETTE SOFT references stocked by ALLPARA for professional use, sourced direct and certified on every shipment.
SILHOUETTE SOFT Products
View all 2
Needle, Cannulas & Threads
Clinic alternatives
/ Recently viewed
Pick up where you left off
MaiLi Extreme
In stock
CE Marked
MaiLi Extreme is an injectable hyaluronic acid dermal filler manufactured by Sinclair Pharma in Switzerland, with 24 mg/mL hyaluronic acid. As a MaiLi Extreme filler, it is a hyaluronic acid gel cross-linked with BDDE, designed for facial volume restoration, including volume loss from HIV-associated lipoatrophy. The product contains lidocaine 3 mg/mL for a more comfortable injection experience, is injected into the subcutaneous fat tissue or supraperiosteal zone, is supplied as four 1 mL syringes with four 27G x 1/2" needles, and is intended strictly for professional use.
Key Benefits of MaiLi Extreme
- Provides facial volume restoration
- Highest hyaluronic acid concentration in the MaiLi range (24 mg/mL)
- For reconstruction of structural defects, including HIV-associated lipoatrophy
- Injected into the subcutaneous fat or supraperiosteal zone by trained specialists
- Contains lidocaine 3 mg/mL for improved treatment comfort
- Hyaluronic acid cross-linked with BDDE
- CE-marked medical device (CE 2797)
Indications and Professional Use
Main indications
- Restoration of facial volume
- Structural defect correction, including congenital or medically related facial volume defects
- Volume loss due to HIV-associated lipoatrophy
Professional use
MaiLi Extreme is for use by authorised healthcare professionals only, injected into the subcutaneous fat tissue or the supraperiosteal zone - reserved to specialists specifically trained in these injection techniques. Composition: cross-linked (BDDE) hyaluronic acid 24 mg/mL of biofermentative origin, with lidocaine hydrochloride 3 mg/mL, in phosphate buffer. Supplied as four 1 mL pre-filled syringes with four 27G x 1/2" needles. Contraindicated in: known hypersensitivity to hyaluronic acid, lidocaine or amide-type local anaesthetics; history of severe allergy or anaphylaxis; autoimmune disease; porphyria; cutaneous disorders, inflammation or infection at or near the treatment site; bleeding disorders or treatment with thrombolytics or anticoagulants; tendency to keloid or hypertrophic scarring; pregnancy or breastfeeding; children.
Treatment areas
- Face
Patient profile
Suitable for adult patients seeking facial volume restoration or reconstruction of structural defects including volume loss from HIV-associated lipoatrophy, as assessed by a qualified practitioner. Not for use in patients with hypersensitivity to hyaluronic acid, lidocaine or amide anaesthetics; autoimmune disease; porphyria; bleeding disorders or anticoagulant therapy; a tendency to keloid or hypertrophic scarring; or during pregnancy or breastfeeding, and not for children. Injection into the subcutaneous fat or supraperiosteal zone is reserved to specialists specifically trained in these techniques.
How MaiLi Extreme Works
MaiLi Extreme is a cross-linked hyaluronic acid gel of biofermentative origin, cross-linked with BDDE, containing hyaluronic acid at 24 mg/mL - the highest in the MaiLi range - with lidocaine hydrochloride 3 mg/mL to reduce discomfort during injection. It is injected into the subcutaneous fat tissue or the supraperiosteal zone by an authorised healthcare professional trained in these techniques, using the supplied 27G x 1/2" needle, for facial volume restoration, including volume loss from HIV-associated lipoatrophy. The gel creates volume that corrects facial anatomy and is fully resorbed over time; how long the effect lasts depends on the quantity injected, the depth of placement and the patient's metabolism.
Why Order From Allpara
Allpara offers genuine, verified MAILI products with full batch-traceability, CE-certified stock, fast EU-wide delivery and expert after-sales support.
Frequently Asked Questions
How long does MaiLi Extreme last?
The gel is fully resorbed over time; how long the effect lasts depends on the quantity injected, the depth of placement and the patient's metabolism.
Which areas can be treated with MaiLi Extreme?
The face, for facial volume restoration and reconstruction of structural defects including volume loss from HIV-associated lipoatrophy. It is injected into the subcutaneous fat or supraperiosteal zone.
What is in MaiLi Extreme?
Cross-linked (BDDE) hyaluronic acid at 24 mg/mL of biofermentative origin - the highest in the MaiLi range - with lidocaine hydrochloride 3 mg/mL, in phosphate buffer.
More from Sinclair
View laboratory →* Professional-use product. Packaging may vary by batch or market. Refer to the supplied IFU for full directions and contraindications.